Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain

INTRODUCTION: The effectiveness, safety, and cost-effectiveness of the use of Souvenaid for Alzheimer’s disease (AD) have been previously evidenced. To complete the economic analysis, there is a need to assess whether society can afford it. The objective of this study was to carry out a budget impac...

Descripción completa

Detalles Bibliográficos
Autores principales: Mar, Javier, Ibarrondo, Oliver, Larrañaga, Igor, Mar-Barrutia, Lorea, Soto-Gordoa, Myriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652901/
https://www.ncbi.nlm.nih.gov/pubmed/36371267
http://dx.doi.org/10.1186/s13195-022-01111-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652901/
https://www.ncbi.nlm.nih.gov/pubmed/36371267
http://dx.doi.org/10.1186/s13195-022-01111-7

Ejemplares similares